Viewing Study NCT03267303


Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2026-01-02 @ 8:29 AM
Study NCT ID: NCT03267303
Status: COMPLETED
Last Update Posted: 2025-02-28
First Post: 2017-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety and Efficacy of TS-091 in Patients with Narcolepsy
Sponsor: Taisho Pharmaceutical Co., Ltd.
Organization:

Study Overview

Official Title: A Phase II, Double-blind, Parallel-group Comparative Study 2 of TS-091 in Patients with Narcolepsy
Status: COMPLETED
Status Verified Date: 2019-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to investigate the efficacy and safety after administration of TS-091 compared with placebo in patients with narcolepsy.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
JapicCTI-173689 OTHER JapicCTI View